198 related articles for article (PubMed ID: 22566746)
1. Mixed dyslipidemias in primary care patients in France.
Laforest L; Ambegaonkar BM; Souchet T; Sazonov V; Van Ganse E
Vasc Health Risk Manag; 2012; 8():247-54. PubMed ID: 22566746
[TBL] [Abstract][Full Text] [Related]
2. Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.
Van Ganse E; Laforest L; Burke T; Phatak H; Souchet T
Clin Ther; 2007 Aug; 29(8):1671-81. PubMed ID: 17919548
[TBL] [Abstract][Full Text] [Related]
3. Attainment of normal lipid levels among high cardiovascular risk patients: pooled analysis of observational studies from the United Kingdom, Sweden, Spain and Canada.
Ambegaonkar BM; Bash LD; Chirovsky DR; Jameson K; Grant S; Nocea G; Pettersson B; Sazonov V
Eur J Intern Med; 2013 Oct; 24(7):656-63. PubMed ID: 23953848
[TBL] [Abstract][Full Text] [Related]
4. Residual dyslipidaemia after statin treatment in France: Prevalence and risk distribution.
Ferrières J; Bérard E; Crisan O; Bongard V
Arch Cardiovasc Dis; 2010 May; 103(5):302-9. PubMed ID: 20619240
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and overlap of different lipid abnormalities in statin-treated patients at high cardiovascular risk in clinical practice in Germany.
Gitt AK; Jünger C; Smolka W; Bestehorn K
Clin Res Cardiol; 2010 Nov; 99(11):723-33. PubMed ID: 20521058
[TBL] [Abstract][Full Text] [Related]
6. Persistent lipid abnormalities in statin-treated patients and predictors of LDL-cholesterol goal achievement in clinical practice in Europe and Canada.
Gitt AK; Drexel H; Feely J; Ferrières J; Gonzalez-Juanatey JR; Thomsen KK; Leiter LA; Lundman P; da Silva PM; Pedersen T; Wood D; Jünger C; Dellea PS; Sazonov V; Chazelle F; Kastelein JJ;
Eur J Prev Cardiol; 2012 Apr; 19(2):221-30. PubMed ID: 21450578
[TBL] [Abstract][Full Text] [Related]
7. Residual dyslipidemia according to low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B among statin-treated US adults: National Health and Nutrition Examination Survey 2009-2010.
Wong ND; Chuang J; Zhao Y; Rosenblit PD
J Clin Lipidol; 2015; 9(4):525-32. PubMed ID: 26228670
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and risk distribution of residual dyslipidemia in statin-treated patients in Greece.
Liberopoulos E; Vlasserou F; Mitrogianni Z; Papageorgantas I; Elisaf M;
Angiology; 2012 Apr; 63(3):184-93. PubMed ID: 21676964
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of dyslipidaemia in statin-treated patients in South Africa: results of the DYSlipidaemia International Study (DYSIS).
Raal FJ; Blom DJ; Naidoo S; Bramlage P; Brudi P
Cardiovasc J Afr; 2013 Sep; 24(8):330-8. PubMed ID: 24240385
[TBL] [Abstract][Full Text] [Related]
10. Obesity, ultrasound indexes of fat depots and lipid goal attainment in patients with high and very high cardiovascular risk: A novel approach towards better risk reduction.
Haberka M; Okopień B; Gąsior Z
Nutr Metab Cardiovasc Dis; 2016 Feb; 26(2):123-33. PubMed ID: 26830392
[TBL] [Abstract][Full Text] [Related]
11. Sex disparity persists in the prevention of cardiovascular disease in women on statin therapy compared to that in men.
Moreno-Arellano S; Delgado-de-Mendoza J; Santi-Cano MJ
Nutr Metab Cardiovasc Dis; 2018 Aug; 28(8):810-815. PubMed ID: 29754716
[TBL] [Abstract][Full Text] [Related]
12. Improving statin treatment strategies to reduce LDL-cholesterol: factors associated with targets' attainment in subjects with and without type 2 diabetes.
Morieri ML; Perrone V; Veronesi C; Degli Esposti L; Andretta M; Plebani M; Fadini GP; Vigili de Kreutzenberg S; Avogaro A
Cardiovasc Diabetol; 2021 Jul; 20(1):144. PubMed ID: 34271920
[TBL] [Abstract][Full Text] [Related]
13. Persistent dyslipidemia in statin-treated patients: the focus on comprehensive lipid management survey in Swiss patients.
Sudano I; Hess L; Noll G; Arnet D
Swiss Med Wkly; 2011; 141():w13200. PubMed ID: 21574067
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of Dyslipidemia and Availability of Lipid-Lowering Medications Among Primary Health Care Settings in China.
Lu Y; Zhang H; Lu J; Ding Q; Li X; Wang X; Sun D; Tan L; Mu L; Liu J; Feng F; Yang H; Zhao H; Schulz WL; Krumholz HM; Pan X; Li J;
JAMA Netw Open; 2021 Sep; 4(9):e2127573. PubMed ID: 34586366
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of dyslipidemia and lipid goal attainment in statin-treated subjects from 3 data sources: a retrospective analysis.
Jones PH; Nair R; Thakker KM
J Am Heart Assoc; 2012 Dec; 1(6):e001800. PubMed ID: 23316314
[TBL] [Abstract][Full Text] [Related]
16. Utilization of lipid-modifying therapy and low-density lipoprotein cholesterol goal attainment in patients at high and very-high cardiovascular risk: Real-world evidence from Germany.
März W; Dippel FW; Theobald K; Gorcyca K; Iorga ŞR; Ansell D
Atherosclerosis; 2018 Jan; 268():99-107. PubMed ID: 29197254
[TBL] [Abstract][Full Text] [Related]
17. Total lipid management and cardiovascular disease in the dyslipidemia international study.
Ferrières J; Amber V; Crisan O; Chazelle F; Jünger C; Wood D
Cardiology; 2013; 125(3):154-63. PubMed ID: 23736147
[TBL] [Abstract][Full Text] [Related]
18. Frequency of Attainment of Low-Density Lipoprotein Cholesterol and Non-High-Density Lipoprotein Cholesterol Goals in Cardiovascular Clinical Practice (from the National Cardiovascular Data Registry PINNACLE Registry).
Spinler SA; Cziraky MJ; Willey VJ; Tang F; Maddox TM; Thomas T; Dueñas GG; Virani SS;
Am J Cardiol; 2015 Aug; 116(4):547-53. PubMed ID: 26089010
[TBL] [Abstract][Full Text] [Related]
19. The therapeutic management of South African dyslipidaemic patients at very high cardiovascular risk (CARDIO TRACK): a cross-sectional study.
Blom DJ; Ranjith N; Joshi P; Naidoo P; van Tonder A; Musa MG; Joshi S; Leisegang R; Trokis JS; Makan H; Raal FJ
Cardiovasc J Afr; 2020; 31(5):245-251. PubMed ID: 33151240
[TBL] [Abstract][Full Text] [Related]
20. Statin utilization and lipid goal attainment in high or very-high cardiovascular risk patients: Insights from Italian general practice.
Arca M; Ansell D; Averna M; Fanelli F; Gorcyca K; Iorga ŞR; Maggioni AP; Paizis G; Tomic R; Catapano AL
Atherosclerosis; 2018 Apr; 271():120-127. PubMed ID: 29499359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
